EUVIMEDEUVIMED entdecken
Crossref

Roux-en-Y gastric bypass improves liver and glucose homeostasis in Zucker diabetic fatty rats by upregulating hepatic trefoil factor family 3 and activating the phosphatidylinositol 3-kinase/protein kinase B pathway

Ke Song, Xiangxin Kong, Yin Xian, Zhenghang Yu, Ming He, Dingqi Xiao, Dianyuan Liang, Zhongyang Zhang, Ting Liu, Ziyan Huang, Xinxin Liao, Yixing Ren

Surgery for Obesity and Related Diseases · 2025

DOI: 10.1016/j.soard.2024.12.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery for Obesity and Related Diseases, 2025. Verfasst von Ke Song und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China; Institute of Hepatobiliary Pancreatic Intestin…. Hauptthemen laut MEDLINE: Gastric Bypass, Trefoil Factor-3, Proto-Oncogene Proteins c-akt, Liver. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Bureau of Science and Technology Nanchong City, Sichuan Province Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Roux-en-Y gastric bypass (RYGB) surgery is effective in ameliorating type 2 diabetes mellitus (T2DM); but its mechanism remains incompletely understood. OBJECTIVES: This study aimed to investigate whether RYGB improves glucose metabolism by upregulating hepatic trefoil factor family 3 (TFF3) and thereby activating the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway. SETTING: Affiliated Hospital of North Sichuan Medical college in Nanchong city, China. METHODS: Zucker diabetic fatty (ZDF) rats underwent RYGB or sham surgery (SHAM), and Zucker lean (ZL) rats served as controls (CON). TFF3 expression and PI3K/Akt pathway activity were compared between groups using western blot, immunofluorescence, and RT-qPCR. Adeno-associated virus (AAV) was used to specifically overexpress and interfere with hepatic TFF3. Liver fibrosis and steatosis were assessed using Masson trichrome and Oil Red O staining. HepG2 cells overexpressing or knocking out TFF3 were constructed using lentiviral transfection and CRISPR/Cas9 technology. After verifying the activity of the PI3K/Akt pathway by western blot, rescue experiments were performed on HepG2 cell overexpressing and knocking out TFF3 using LY294002 and 740Y-P, respectively. The activities of gluconeogenic enzymes and glucose uptake capacity in different HepG2 cells were evaluated using qPCR and flow cytometry. RESULTS: Compared with the SHAM group, the blood glucose, body weight, insulin resistance, and lipid metabolism of ZDF rats in the RYGB group were significantly improved. The expression of TFF3 and PI3K/Akt phosphorylation in the liver of the RYGB group were higher than those of the rats that had undergone SHAM. In addition, compared with the SHAM group, the liver fibrosis and fatty degeneration of RYGB rats were milder, and the activity of gluconeogenic enzymes was lower. After tail vein injection of AAV that specifically overexpresses liver TTF3 in rats in the SHAM group, rats' insulin resistance, glucose tolerance, gluconeogenic enzymes, and other glucose metabolism indicators improved. After tail vein injection of AAV that interferes with liver TFF3 in rats in the RYGB group, rats' glucose metabolism indicators deteriorated. In in vitro experiments, the PI3K/Akt activity of TFF3-knocked-out HepG2 cells was lower than that of other groups. Lower glucose concentration were observed in TFF3-overexpressing cell lines. After rescue experiments, differences were found. The glucose metabolism level of the TFF3-expressing HepG2 cell line was positively correlated with the activity of the PI3K/Akt pathway. CONCLUSIONS: RYGB regulates the expression of TFF3 in the liver of ZDF rats, thereby activating the PI3K/Akt pathway and improving T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastric BypassTrefoil Factor-3Proto-Oncogene Proteins c-aktLiverPhosphatidylinositol 3-KinaseAnimalsRats, ZuckerRatsSignal TransductionMaleUp-RegulationHumansGlucoseHomeostasisInsulin ResistanceDiabetes Mellitus, Type 2Hep G2 CellsBlood GlucosePhosphatidylinositol 3-Kinases

Stichwörter der Autor:innen

AktPI3KRYGBT2DMTFF3

Substanzen

Trefoil Factor-3Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinaseGlucoseBlood GlucosePhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China; Institute of Hepatobiliary Pancreatic Intestinal Diseases, North Sichuan Medical College, Nanchong, China.
  • Academy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin, China.
  • Department of Otolaryngology & Head and Neck Surgery, Nanchong Psychosomatic Hospital, Nanchong, China.
  • Department of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
  • Institute of Hepatobiliary Pancreatic Intestinal Diseases, North Sichuan Medical College, Nanchong, China.
  • Department of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China; General Surgery, Chengdu XinHua Hospital Affiliated to North Sichuan Medical College, Chengdu, China. Electronic add…

Förderung

  • Bureau of Science and Technology Nanchong City
  • Sichuan Province Health Commission
  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Song, K., Kong, X., Xian, Y., Yu, Z., He, M., Xiao, D., Liang, D., Zhang, Z., Liu, T., Huang, Z., Liao, X., & Ren, Y. (2025). Roux-en-Y gastric bypass improves liver and glucose homeostasis in Zucker diabetic fatty rats by upregulating hepatic trefoil factor family 3 and activating the phosphatidylinositol 3-kinase/protein kinase B pathway. Surgery for Obesity and Related Diseases. https://doi.org/10.1016/j.soard.2024.12.024

Vancouver

Song K, Kong X, Xian Y, Yu Z, He M, Xiao D, et al. Roux-en-Y gastric bypass improves liver and glucose homeostasis in Zucker diabetic fatty rats by upregulating hepatic trefoil factor family 3 and activating the phosphatidylinositol 3-kinase/protein kinase B pathway. Surgery for Obesity and Related Diseases. 2025. doi:10.1016/j.soard.2024.12.024

BibTeX
@article{Song2025,
  author = {Song, Ke and Kong, Xiangxin and Xian, Yin and Yu, Zhenghang and He, Ming and Xiao, Dingqi and Liang, Dianyuan and Zhang, Zhongyang and Liu, Ting and Huang, Ziyan and Liao, Xinxin and Ren, Yixing},
  title = {Roux-en-Y gastric bypass improves liver and glucose homeostasis in Zucker diabetic fatty rats by upregulating hepatic trefoil factor family 3 and activating the phosphatidylinositol 3-kinase/protein kinase B pathway},
  journal = {Surgery for Obesity and Related Diseases},
  year = {2025},
  doi = {10.1016/j.soard.2024.12.024}
}
Kostenlos starten →